Offer - Urjas Oil for just Rs 1
Afdiex 2.5 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Diabetes Type 2. Afdiex 2.5 Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Afdiex 2.5 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Afdiex 2.5 Tablet have been listed ahead. Normally, these side effects of Afdiex 2.5 Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Afdiex 2.5 Tablet's effect is Severe during pregnancy and Severe for lactating mothers. In addition, Afdiex 2.5 Tablet's effects on the liver, heart and kidney are discussed below in the Afdiex 2.5 Tablet related warnings section.
Afdiex 2.5 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Kidney Disease, Heart Disease are examples of such conditions. Some other conditions that can be affected by Afdiex 2.5 Tablet are listed in the contraindications section below.
Additionally, Afdiex 2.5 Tablet may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Afdiex 2.5 Tablet is considered safe while driving, and is addictive.
Afdiex 2.5 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Afdiex 2.5 Tablet safe for pregnant women?
Afdiex has many dangerous side effects in pregnant women. If you are pregnant, do not consume Afdiex without medical advice.
Is the use of Afdiex 2.5 Tablet safe during breastfeeding?
Taking Afdiex may lead to serious side effects if you are breastfeeding. Afdiex should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Afdiex 2.5 Tablet on the Kidneys?
Afdiex may have severe effects on your kidney, so do not take it without consulting your doctor.
What is the effect of Afdiex 2.5 Tablet on the Liver?
Afdiex may have severe effects on your liver, so do not take it without first consulting your doctor.
What is the effect of Afdiex 2.5 Tablet on the Heart?
Afdiex may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Afdiex 2.5 Tablet unless your doctor advises you to do so -
Is this Afdiex 2.5 Tablet habit forming or addictive?
No, there is no any evidence that Afdiex 2.5 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Afdiex 2.5 Tablet does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Afdiex 2.5 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Afdiex 2.5 Tablet in mental disorders is not effective.
Interaction between Food and Afdiex 2.5 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Afdiex 2.5 Tablet together with food.
Interaction between Alcohol and Afdiex 2.5 Tablet
Consumption of alcohol and Afdiex 2.5 Tablet together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glynase® PresTab® (micronized glyburide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272